A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

NCT04004234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer (BTC)

Interventions

DRUG: Manganese Chloride
DRUG: nab-paclitaxel
DRUG: Gemcitabine
DRUG: anti-PD-1 antibody

Sponsor

Chinese PLA General Hospital